Familial Pulmonary Fibrosis clinical trials

Explore recruiting familial pulmonary fibrosis clinical trials.

Recruiting familial pulmonary fibrosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Familial Pulmonary Fibrosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A double blind, randomized, placebo-controlled exploratory trial to investigate the efficacy and safety of nerandomilast over 24 months when administered in individuals with interstitial lung abnormalities and a family history of pulmonary fibrosis to reduce the risk of worsening (DROP-FPF)

Belgium, Spain, Netherlands, Italy, Germany, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Familial Pulmonary Fibrosis trials by city

Familial Pulmonary Fibrosis in Toronto Familial Pulmonary Fibrosis in Vancouver Familial Pulmonary Fibrosis in Montreal Familial Pulmonary Fibrosis in Calgary Familial Pulmonary Fibrosis in Edmonton Familial Pulmonary Fibrosis in Ottawa Familial Pulmonary Fibrosis in Winnipeg Familial Pulmonary Fibrosis in Quebec City Familial Pulmonary Fibrosis in Hamilton Familial Pulmonary Fibrosis in Kitchener Familial Pulmonary Fibrosis in London Familial Pulmonary Fibrosis in Halifax Familial Pulmonary Fibrosis in New York Familial Pulmonary Fibrosis in Los Angeles Familial Pulmonary Fibrosis in Chicago Familial Pulmonary Fibrosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease